Weekly shot tested to control HIV, could ease treatment burden
NCT ID NCT06061536
Summary
This study tested a new, long-acting injectable drug called Lipovirtide for people newly diagnosed with HIV who had not yet started treatment. The goal was to see if giving this injection once a week or once every two weeks, along with daily pills, could effectively control the virus and be safe. Researchers compared different doses of the injection against a standard daily pill regimen in 64 participants over about six months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Tianjin Second People's Hospital
Tianjin, Tianjin Municipality, 300000, China
Conditions
Explore the condition pages connected to this study.